<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Elevations in alanine aminotransferase (ALT) and Î³-<z:chebi fb="0" ids="32483">glutamyl</z:chebi> transferase (GGT), surrogate markers of <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> and nonalcoholic <z:hpo ids='HP_0001397'>fatty liver</z:hpo>, are considered as part of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and related type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, information is limited regarding the long-term predictability of ALT and GGT in the development of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: In this retrospective cohort study, normoglycemic (n = 874), <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> (n = 101), and diabetic (n = 80) adults aged 26-50 years (average age 41.3 years) were followed over an average period of 16 years since their young adulthood (aged 18-38 years, average age 25.1 years), with measurements of cardiometabolic risk factor variables including ALT and GGT </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The follow-up prevalence rate of adult <z:mp ids='MP_0002055'>diabetes</z:mp> status by quartiles of baseline ALT and GGT levels showed an adverse trend for both <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> (P &lt; 0.05) and <z:mp ids='MP_0002055'>diabetes</z:mp> (P &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>In a longitudinal multivariate logistic regression analysis that included anthropometric, hemodynamic, and metabolic variables, as well as alcohol consumption and smoking, individuals with elevated baseline ALT and GGT levels (per 1-SD increment) were 1.16 and 1.20 times, respectively, more likely to develop <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.05 for ALT and P &lt; 0.01 for GGT); no such associations were noted for <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Regarding the predictive value of ALT and GGT, the area under the receiver operating curve analysis yielded C values ranging from 0.70 to 0.82, with values significantly higher for <z:mp ids='MP_0002055'>diabetes</z:mp> compared with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: These findings in younger adults suggest potential clinical utility of including ALT and GGT as biomarkers in <z:mp ids='MP_0002055'>diabetes</z:mp> risk assessment formulations </plain></SENT>
</text></document>